Thomas Andrew Crockett - Insider Trading & Ownership

Entity
Individual
Location
Building 227, Tetricus Science Park, Porton Down, Salisbury, Wiltshire, United Kingdom
Summary
The estimated net worth of Thomas Andrew Crockett is at least $4.65M dollars as of February 21, 2024. Thomas Andrew Crockett is the CEO, Director of KalVista Pharmaceuticals, Inc. and owns shares of KalVista Pharmaceuticals, Inc. (KALV) stock worth about $4.65M.
All Insider Reports
All Insider Reports

Ownership of Thomas Andrew Crockett

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KALV KalVista Pharmaceuticals, Inc. CEO, Director $4.65M -$1.87M -28.7% Feb 17, 2024

Insider Transactions Reported by Thomas Andrew Crockett:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.